IQV Leverages Nvidia AI to Transform Life Sciences Efficiency

IQVIA Holdings Inc. (NYSE: IQV) announced the launch of IQVIA.ai, a unified agentic AI platform developed in partnership with Nvidia, on March 16. The platform is designed specifically for the life sciences industry to improve operational efficiency and decision-making processes. According to the company, the new platform leverages Nvidia's AI and accelerated computing technologies to provide a scalable foundation for applications across clinical development, commercial operations, and real-world data analysis. IQVIA stated the platform aims to help biopharma companies accelerate innovation and bring therapies to patients more effectively. Analysts have identified IQVIA as a top large-cap value stock to consider buying.